Innovative Trials are passionate about ensuring our diverse population is adequately represented within medical research. Whether it is wanting to see more people from underrepresented communities choosing science as a career and pushing for greater patient diversity in clinical trials or focusing on what we are doing internally to celebrate and promote equality and diversity,
Innovative Trials are passionate about ensuring our diverse population is adequately represented within medical research. Whether it is wanting to see more people from underrepresented communities choosing science as a career and pushing for greater patient diversity in clinical trials or focusing on what we are doing internally to celebrate and promote equality and diversity,
Artificial intelligence (AI) in clinical research has the potential to accelerate patient access to new treatments by streamlining the drug development process and helping to generate more robust data, which will inevitably aid regulatory decision-making. But alongside AI’s potential promise comes several challenges that the pharmaceutical industry will need to consider – and
Several factors affect clinical trial success, such as patient recruitment and retention, protocol design and compliance, study duration, and high-quality partnerships between sponsors and non-industry collaborators1. But success can also rely on other circumstances like political decisions, technological advances and financial uncertainties. So far this year, we have witnessed several announcements that could
Innovative Trials are passionate about ensuring our diverse population is adequately represented within medical research. Whether it is wanting to see more people from underrepresented communities choosing science as a career and pushing for greater patient diversity in clinical trials or focusing on what we are doing internally to celebrate and promote equality and diversity,
Innovative Trials are passionate about ensuring our diverse population is adequately represented within medical research. Whether it is wanting to see more people from underrepresented communities choosing science as a career and pushing for greater patient diversity in clinical trials or focusing on what we are doing internally to celebrate and promote equality and diversity,
In 2024, the Innovative Trials team continued to push the boundaries of clinical trial patient recruitment and retention more than ever. We have always believed the most successful strategies center around patients’ lives and needs, which led us to launch our Patient Support Center (Navigator) in 2023 and the Retention Patch Program for
Influenza (flu) vaccines are a staple part of keeping people well during the winter months. As the nights get darker and flu season across the Northern Hemisphere intensifies, many depend on an annual vaccine to prevent them from getting seriously ill. Equally, those who get sick with flu benefit from treatments such as
Innovative Trials are passionate about ensuring our diverse population is adequately represented within medical research. Whether it is wanting to see more people from underrepresented communities choosing science as a career and pushing for greater patient diversity in clinical trials or focusing on what we are doing internally to celebrate and promote equality and diversity,
Innovative Trials are passionate about ensuring our diverse population is adequately represented within medical research. Whether it is wanting to see more people from underrepresented communities choosing science as a career and pushing for greater patient diversity in clinical trials or focusing on what we are doing internally to celebrate and promote equality and diversity,